Etges, T., Karolia, K., Grint, T., Taylor, A., Lauder, H., Daka, B., & Wright, S. (2016). An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex(®) (THC: CBD, nabiximols) oromucosal spray. Ther Clin Risk Manag.
Stile di citazione ChicagoEtges, Tilden, Kari Karolia, Thomas Grint, Adam Taylor, Heather Lauder, Brian Daka, e Stephen Wright. "An Observational Postmarketing Safety Registry of Patients in the UK, Germany, and Switzerland Who Have Been Prescribed Sativex(®) (THC: CBD, Nabiximols) Oromucosal Spray." Ther Clin Risk Manag 2016.
Citazione MLAEtges, Tilden, et al. "An Observational Postmarketing Safety Registry of Patients in the UK, Germany, and Switzerland Who Have Been Prescribed Sativex(®) (THC: CBD, Nabiximols) Oromucosal Spray." Ther Clin Risk Manag 2016.